Many features like drug resistance and difficulty in the transport of PDL-1 antibodies to the tumor sites can be rectified by AuNPs, since AuNPs, due to their surface properties, pass through the tumor micro-environment barrier easily along with the conjugated antibodies and drugs. The gene discussed is CD274; the disease is neoplasm.